by H.S. Ayoub
BioHealth Investor.com
Biotechnology
INTL STEM CELL CORP [ISCO.OB] +18.11%
OBAGI MEDICAL [OMPI] +13.83%
NABI BIOPHARMACEUT [NABI] +11.28%
ZIOPHARM ONCOLOGY IN [ZIOP] +11.11%
HESKA CORPORATION [HSKA] +10.80%
Diagnostic Substances
NYMOX PHARM CORP [NYMX] +8.13%
IMMUCOR INC [BLUD] +5.96%
GENE LOGIC INC [GLGC] +5.26%
INTERLEUKIN GENETICS [ILI] +4.89%
SYNTA PHARMACEUTICAL [SNTA]
Drug Delivery
EMISPHERE TECH [EMIS] +5.54%
NOVADEL PHARMA INC [NVD] +4.75%
SKYEPHARMA PLC [SKYE] +4.09%
NOVEN PHARMACEUTIC [NOVN] +3.48%
COLUMBIA LABS INC [CBRX] +3.40%
Drug Manufacturers
PAIN THERAPEUTICS [PTIE] +14.90%
JAVELIN PHARMACEUTIC [JAV] +13.20%
ANGIOTECH PHARMA I [ANPI] +12.78%
PROVECTUS PHARMA [PVCT.OB] +8.39%
NOVO NORDISK A S [NVO] +6.66%
Drug Related Products
XELR8 HOLDINGS, INC [BZI] +11.06%
SALIX PHARM DEL [SLXP] +3.25%
PACIFICHEALTH LABS [PHLI.OB] +3.09%
TIENS BIOTECH GR USA [TBV] +2.69%
N B T Y INC [NTY] +1.69%
Generic Drugs
WATSON PHARMACEUTCLS [WPI] +4.00%
ISOLAGEN INC [ILE] +3.78%
BARR PHARMA INC [BRL] +2.63%
CARACO PHARMA LABS [CPD] +1.54%
MYLAN LABS INC [MYL] +0.90%
Medical Appliances & Equipment
FONAR CORP NEW [FONRD] +11.41%
NON INVASIVE MONITORNG SYS NEW [NIMU.OB] +11.25%
SPAN AMERICA MED S [SPAN] +10.36%
ACCURAY INCORPORATED [ARAY] +10.25%
CRYOLIFE INC [CRY] +8.50%
Medical Instruments & Supplies
APA ENTERPRISES [APAT] +24.37%
IMPLANT SCIENCES CP [IMX] +9.50%
HEMOSENSE INC. [HEM] +9.48%
HAEMONETICS CP [HAE] +9.33%
MERIT MEDICAL SYS [MMSI] +6.02%
Medical Laboratories & Research
NATL DENTEX CP [NADX] +8.35%
AETERNA ZENTARIS [AEZS] +4.97%
NEOGENOMICS INC [NGNM.OB] +4.38%
ENZO BIOCHEM INC [ENZ] +3.46% $
ERESEARCHTECHNOLOG [ERES] +1.96%
Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.